Improving the efficacy of translational medicine by optimally integrating health care, academia and industry.
作者信息
Bornstein Stefan R, Licinio Julio
机构信息
University Clinic Carl-Gustav-Carus, Technical University, Dresden, Dresden, Germany.
出版信息
Nat Med. 2011 Dec 6;17(12):1567-9. doi: 10.1038/nm.2583.
Abstract
摘要
相似文献
1
Improving the efficacy of translational medicine by optimally integrating health care, academia and industry.
Nat Med. 2011 Dec 6;17(12):1567-9. doi: 10.1038/nm.2583.
2
Academia-pharma partnerships for novel drug discovery: essential or nice to have?
Expert Opin Drug Discov. 2017 Jun;12(6):537-540. doi: 10.1080/17460441.2017.1318124. Epub 2017 Apr 17.
3
Building a new biomedical ecosystem: Pfizer's Centers for Therapeutic Innovation.
Clin Pharmacol Ther. 2013 Sep;94(3):314-6. doi: 10.1038/clpt.2013.89. Epub 2013 May 3.
4
Playing well with others! Initiating and sustaining successful collaborations between industry, academia and government.
Curr Top Med Chem. 2014;14(3):291-3. doi: 10.2174/1568026613666131127125351.
5
An audience with...Francis Collins. Interviewed by Asher Mullard.
Nat Rev Drug Discov. 2011 Jan;10(1):14. doi: 10.1038/nrd3357. Epub 2010 Dec 10.
6
[Address from the previous President, January 17, 2013].
Rev Neurol (Paris). 2013 Mar;169(3):214-5. doi: 10.1016/j.neurol.2013.01.001. Epub 2013 Feb 28.
7
Funding bodies should foster partnerships between industry and academia.
Nat Rev Cancer. 2021 Feb;21(2):65-66. doi: 10.1038/s41568-020-00326-w.
8
Leveraging public private partnerships to innovate under challenging budget times.
Curr Top Med Chem. 2014;14(3):326-9. doi: 10.2174/1568026613666131127155703.
9
Competition: Unlikely partnerships.
Nature. 2016 May 12;533(7602):S56-8. doi: 10.1038/533S56a.
10
Open PHACTS: semantic interoperability for drug discovery.
Drug Discov Today. 2012 Nov;17(21-22):1188-98. doi: 10.1016/j.drudis.2012.05.016. Epub 2012 Jun 7.
引用本文的文献
1
The emergence of chronic diseases of adulthood and middle age in the young: the COIDS (chronic inflammation, obesity, insulin resistance/type 2 diabetes, and depressive syndromes) noxious quartet of pro-inflammatory stress outcomes.
Mol Psychiatry. 2025 May 2. doi: 10.1038/s41380-025-03034-9.
2
Bridging the Divide: A Review on the Implementation of Personalized Cancer Medicine.
J Pers Med. 2024 May 24;14(6):561. doi: 10.3390/jpm14060561.
3
Advances in Molecular Psychiatry - March 2023: mitochondrial function, stress, neuroinflammation - bipolar disorder, psychosis, and Alzheimer's disease.
Mol Psychiatry. 2023 Mar;28(3):968-971. doi: 10.1038/s41380-023-01968-6. Epub 2023 Feb 7.
4
Benefits, Facilitators, and Recommendations for Digital Health Academic-Industry Collaboration: A Mini Review.
Front Digit Health. 2021 Apr 15;3:616278. doi: 10.3389/fdgth.2021.616278. eCollection 2021.
5
Advances in autism research, 2021: continuing to decipher the secrets of autism.
Mol Psychiatry. 2021 May;26(5):1426-1428. doi: 10.1038/s41380-021-01168-0. Epub 2021 May 28.
6
Advances in depression research: second special issue, 2020, with highlights on biological mechanisms, clinical features, co-morbidity, genetics, imaging, and treatment.
Mol Psychiatry. 2020 Jul;25(7):1356-1360. doi: 10.1038/s41380-020-0798-1.
7
A physician-scientist preceptorship in clinical and translational research enhances training and mentorship.
BMC Med Educ. 2019 Mar 27;19(1):89. doi: 10.1186/s12909-019-1523-0.
8
Developing translational medicine professionals: the Marie Skłodowska-Curie action model.
J Transl Med. 2016 Nov 29;14(1):329. doi: 10.1186/s12967-016-1088-1.
9
Tetramethylpyrazine nitrone, a multifunctional neuroprotective agent for ischemic stroke therapy.
Sci Rep. 2016 Nov 14;6:37148. doi: 10.1038/srep37148.
10
Clinical classification in mental health at the cross-roads: which direction next?
BMC Med. 2013 May 14;11:125. doi: 10.1186/1741-7015-11-125.
本文引用的文献
1
Translational Psychiatry: leading the transition from the cesspool of devastation to a place where the grass is really greener.
Transl Psychiatry. 2011 Apr 4;1(4):e1. doi: 10.1038/tp.2011.3.
2
Why does the United States need a national center for new cures?
Mol Psychiatry. 2011 Sep;16(9):882-4. doi: 10.1038/mp.2011.103.
3
Reengineering translational science: the time is right.
Sci Transl Med. 2011 Jul 6;3(90):90cm17. doi: 10.1126/scitranslmed.3002747.
4
Academic health science centres in Australia: let's get competitive.
Med J Aust. 2011 Jan 17;194(2):59-60. doi: 10.5694/j.1326-5377.2011.tb04165.x.
5
Bridging the Valley of Death of therapeutics for neurodegeneration.
Nat Med. 2010 Nov;16(11):1227-32. doi: 10.1038/nm.2222. Epub 2010 Sep 21.
6
The Herrenhausen symposium on neurodegeneration. Forward.
Nat Med. 2010 Nov;16(11):1200. doi: 10.1038/nm1110-1200.
7
A novel device for islet transplantation providing immune protection and oxygen supply.
Horm Metab Res. 2010 Dec;42(13):918-22. doi: 10.1055/s-0030-1267916. Epub 2010 Oct 28.
8
Academic medicine must take its global role: the M8 Alliance of Academic Health Centers and Medical Universities.
Lancet. 2010 Oct 9;376(9748):1197-8. doi: 10.1016/S0140-6736(10)61549-8.
9
The First International Conference on Translational Medicine.
Mol Psychiatry. 2010 Sep;15(9):878-9. doi: 10.1038/mp.2010.91.
10
Traversing the valley of death: a guide to assessing prospects for translational success.
Sci Transl Med. 2009 Dec 9;1(10):10cm9. doi: 10.1126/scitranslmed.3000265.
Zotero 插件